Stocks

Viking Therapeutics, a biotechnology firm, faced a severe market selloff after presenting clinical data for its oral obesity treatment, VK2735....

A notable institutional investor has scaled back its position in Rocket Lab USA, a move that could signal shifting sentiment...

The competitive landscape for high-bandwidth memory (HBM) chips, crucial for artificial intelligence applications, is shifting. Samsung Electronics, which had previously...

Biotech firm Novavax has unveiled a complex financial restructuring plan aimed at improving its liquidity position, but market participants have...

Vertiv finds itself at the very heart of the artificial intelligence revolution, providing the indispensable infrastructure that powers data centers...

A curious divergence is unfolding at IBM. The technology giant continues to land staggering artificial intelligence contracts, yet its stock...

The US healthcare giant Centene finds itself confronting several simultaneous challenges, from an unsolicited acquisition bid to shareholder litigation and...

Axon Enterprise continues to demonstrate how specialized technology markets can generate extraordinary expansion. The public safety technology pioneer is delivering...

While Exelixis's top-line revenue might initially appear disappointing, a deeper analysis reveals a compelling growth narrative. The biotechnology firm is...

Philip Morris International presents investors with a compelling dichotomy. The company's underlying business metrics demonstrate remarkable robustness, yet its stock...